<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by NU Sci Staff on Medium]]></title>
        <description><![CDATA[Stories by NU Sci Staff on Medium]]></description>
        <link>https://medium.com/@nuscimag?source=rss-7d968cc5324f------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/2*Dz9O8TarRwzDBcA_Oi7HYQ.png</url>
            <title>Stories by NU Sci Staff on Medium</title>
            <link>https://medium.com/@nuscimag?source=rss-7d968cc5324f------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 21 Nov 2026 02:28:50 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@nuscimag/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Opinion: Is female leadership the solution to the pandemic?]]></title>
            <link>https://medium.com/nusci/opinion-is-female-leadership-the-solution-to-the-pandemic-d93c2cef53e4?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/d93c2cef53e4</guid>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[leadership]]></category>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[world]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Mon, 31 Aug 2020 09:11:00 GMT</pubDate>
            <atom:updated>2020-09-09T23:55:14.099Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Maya Krause, Environmental Science, Class of 2022</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/768/0*881ZzJ-vMRiB4SWc.jpg" /></figure><p>On June 8th, New Zealand Prime Minister Jacinda Ardern announced the country had completely eradicated COVID-19, citing no active cases for the first time since February. This news brought celebration, as public gatherings such as sporting events, retail shopping, and hospitality have reopened. As some countries succeed and others struggle in standing up to the challenges of the pandemic, patterns in leadership will emerge. For instance, countries with female leaders have largely been successful at fighting the coronavirus. Does this pattern demonstrate the skills that women bring to leadership, or is it more representative of what comprises a successful leadership style when faced with a crisis?</p><p>Because the coronavirus pandemic is ongoing, no peer-reviewed studies have been conducted that determine any patterns in leadership throughout the pandemic. However, so far, women-led countries have been notably successful in acting quickly and controlling the spread of COVID-19. From Ardern to Finnish Prime Minister Sanna Marin to Taiwanese president Tsai Ing-wen, female leaders around the world have been applauded for their swift and successful action in tackling the pandemic. On March 21st, when New Zealand only had 52 cases of COVID-19, Ardern announced a four-level alert system (Prepare, Reduce, Restrict, Lockdown) and had already closed the country’s border. And when New Zealand entered the Lockdown phase a few days later, Ardern addressed the country on Facebook Live in a sweatshirt, apologizing for the abrupt emergency alert announcing the lockdown that had been sent to citizen’s phones with a “loud honk.”</p><blockquote><em>From Ardern to Finnish Prime Minister Sanna Marin to Taiwanese president Tsai Ing-wen, female leaders around the world have been applauded for their swift and successful action in tackling the pandemic.</em></blockquote><p>Stereotypes associated with female leaders have typically not been viewed as effective leadership strategies, especially in the United States. According to a study by Dr. Kira Sanbonmatsu at the Rutgers Center for American Women and Politics, women’s gender stereotypes (caring, collaborative, community-oriented) are seen as less fitting for political office than male gender stereotypes (power-seeking, strong, combative). Additionally, as explained to <em>The</em> <em>New York Times</em> by Alice Evans, a sociologist at King’s College London, “there is an expectation that leaders should be aggressive and forward and domineering. But if women demonstrate those traits, then they’re seen as unfeminine.” However, during the pandemic, women leaders around the world have succeeded by leading cautiously, but swiftly, and steering away from the combative responses seen used by some male leaders.</p><p>It is possible that the pattern of successful female leadership has more to do with leadership style than gender. Many of the countries with the highest rates of coronavirus mortality, such as the United Kingdom, the United States, and Brazil, have authoritarian, populist leaders who have presented themselves as anti-establishment leaders working for the common folk. These leaders have dismissed the advice of public health professionals surrounding personal protective equipment and banning public gatherings. For example, in the United Kingdom, male Prime Minister Boris Johnson’s government initially encouraged residents to continue socializing while later delivering updated lockdown plans that lacked detail and confused citizens. In contrast, Germany’s female Chancellor Angela Merkel has a doctorate in quantum chemistry and worked as a research scientist prior to becoming a politician. Merkel has handled the coronavirus crisis by calling to her strengths as a scientist, presenting residents of Germany with detailed guidelines to halt the spread of COVID-19. Ultimately, the United Kingdom has seen nearly twice the number of cases of COVID-19 per million residents as Germany, and Britain’s lockdown has continued into June while Germany began to reopen shops in May.</p><blockquote><em>“There is an expectation that leaders should be aggressive and forward and domineering. But if women demonstrate those traits, then they’re seen as unfeminine.”</em></blockquote><p>The pattern of successful female leaders does have outliers. While Belgium has seen one of the world’s highest mortality rates from COVID-19, female Prime Minister Sophie Wilmes has downplayed the severity of the virus, suggesting that health officials may be over-reporting deaths. Health officials have stated that poor preparation along with a high elderly-home population has led to the devastating death toll. And, in South Korea, male President Moon Jae-in has been praised for his quick response in providing personal protective equipment to medical staff, covering all COVID-19 medical expenses, and implementing extensive contact tracing, identifying those who may have come in contact with someone with COVID-19. South Korea has limited the death toll from COVID-19 to 5 deaths per million residents, which is significantly lower than the worldwide death toll of 57.2 deaths per million people.</p><p>As the pandemic continues, with economies battered, healthcare infrastructure vulnerable, and citizens nervous for the future, the leaders who have succeeded in quelling the damage will emerge. The nations that have been the most successful at tackling the virus thus far have been the leaders that have acted quickly, avoided confusion with clear and consistent responses, and remained sympathetic and understanding to the anxieties of the pandemic. Considering many of the successful leaders so far have been women, the pandemic may affect global perception of the strength of female leadership. Furthermore, the impacts of the world leaders who have succeeded in slowing or stopping the pandemic in their nations could alter the perception of what qualities comprise a good leader.</p><p>Image source: Pixabay.</p><p><em>Originally published at </em><a href="https://nuscimagazine.com/opinion-is-female-leadership-the-solution-to-the-pandemic/"><em>https://nuscimagazine.com</em></a><em> on August 31, 2020.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d93c2cef53e4" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/opinion-is-female-leadership-the-solution-to-the-pandemic-d93c2cef53e4">Opinion: Is female leadership the solution to the pandemic?</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Ecological boomerang: How man-made climate change is biting back]]></title>
            <link>https://medium.com/nusci/ecological-boomerang-how-man-made-climate-change-is-biting-back-149c1bed1f5f?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/149c1bed1f5f</guid>
            <category><![CDATA[environment]]></category>
            <category><![CDATA[climate-change]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[earth]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Thu, 20 Aug 2020 17:09:44 GMT</pubDate>
            <atom:updated>2020-08-20T17:09:44.981Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Catrin Zharyy, Behavioral Neuroscience, 2023</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*KBTAxiuuXEUezv5G.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>Over the past few years, a new moral code including owning up to one’s mistakes and vowing to “do better” has swept mainstream American culture. Not only have people taken personal oaths to hold themselves to a higher standard, but they’re expecting more out of their neighbors, law enforcement, local elected officials, global leaders, and even celebrities.</p><p>It’s not surprising that accountability also plays a role in the modern environmental movement, arguably since 2015 when the United Nations published 17 Global Sustainable Development Goals to reach by 2030. Since then, millions have participated in climate strikes, and the 2020 Democratic presidential candidates drafted policies aimed at rectifying the effects of anthropogenic climate change. Both as a global community and nation, people are identifying who and what are at fault for the current frightening state of the natural world. Humanity has caused significant damage to the planet’s atmosphere, oceans, and animal species. In fact, scientists argue that humans have single-handedly caused Earth to enter a new geological epoch: the Anthropocene.</p><blockquote>Humans have single-handedly caused Earth to enter a new geological epoch: the Anthropocene.</blockquote><p>The Anthropocene’s earliest stage, they suggest, began with the arrival of agriculture, domestication of animals, and wide-ranging deforestation. However, geologists claim the official beginning of the epoch was not until the “Great Acceleration” of the mid-20th century, when the rate of world population growth was at its peak and industrialization was on the rise. The Anthropocene epoch is distinct from the previous geological epoch, the Holocene, because of higher global temperatures and sea level; production and dispersion of new materials like concrete and plastics; harmful levels of certain chemicals in the atmosphere, ocean, and soil; and rapid species extinction and displacement.</p><p>The rise in global temperature is largely due to the greenhouse effect: the accumulation of gases such as carbon dioxide, methane, nitrous oxide, and synthetic chlorofluorocarbons (CFCs) that all act to trap heat by absorbing long-wavelength infrared light being reflected by the Earth. The greatest producer of excess carbon dioxide is, of course, the burning of fossil fuels. Using up a gallon of gas in one’s car adds 20 pounds of carbon dioxide to the air. To an extent, the planet can be very helpful in removing some of this carbon dioxide. Oceans can dissolve it, and plants use it in the process of photosynthesis — remarkably, a tree weighing two tons consumes seven tons of carbon dioxide in its lifetime. Unfortunately, exploitative deforestation and industrial agriculture strip such large tracts of land at a time and so quickly that it is simply impossible for forests to grow back at the same rate as they are being depleted.</p><p>Furthermore, global warming leads to more violent weather by changing air and ocean currents and causing a rise in sea levels. It also causes climate zones to move away from the equator and toward the poles, and the equatorial tropic region to shrink. This has drastic effects on the order of the natural world, and, in turn, on human well-being and survival. All species, from animals to plants to disease-carrying bacteria, must either go extinct or adapt to a new man-made environment — putting agriculture, food and water security, public health, and economies in grave trouble.</p><blockquote>All species, from animals to plants to disease-carrying bacteria, must either go extinct or adapt to a new man-made environment — putting agriculture, food and water security, public health, and economies in grave trouble.</blockquote><p>One greenhouse gas, CFCs, not only traps heat, but also eats away at the ozone layer: the Earth’s natural shield for lethal ultraviolet-C rays. CFCs are most often used in refrigeration, air conditioning, spray cans, and making foam plastic. On the surface of ice crystals in the stratosphere, CFC molecules are broken up by ultraviolet radiation to release a form of chlorine that destroys ozone gas. A single molecule of CFC lasts for nearly a century and destroys about 100,000 molecules of ozone. Each winter, the Antarctic vortex seals off the southern pole from warmer surrounding air, enabling more ice crystals to form and more ozone to be depleted until temperatures warm again. All that is needed to patch up ozone holes are free oxygen and the sun’s rays, but climate change can make this process unpredictable from year to year by altering the amount of ice crystals that form at the South Pole. Moreover, if CFCs continue to run rampant in the stratosphere, ultraviolet-C rays can reach the surface and cause painful burns and even cancer before the ozone hole manages to close back up with warmer weather.</p><p>Other dangerous pollutants frequently released into our shared airspace are large quantities of sulfur and nitrogen (causing acid rain), carbon monoxide, ozone gas, toxic chemicals from factory and vehicle exhaust, and radioactive particles. (On the surface of the planet, ozone is extremely reactive and burns living tissue.)</p><p>Oceans and other bodies of water are being massively polluted as well. Acid rain and industrial waste kill whatever marine life they touch, while sewage and fertilizer runoff (containing phosphates and nitrogen, respectively) promote algal blooms and anoxia, which suffocate fish.</p><blockquote>It’s natural for some species to die out every now and then, but the current extinction rate is tens or even hundreds of times as great as what the average rate has been for the past 10 million years.</blockquote><p>Pollution, habitat destruction, overhunting, overfishing, climate change, and the introduction of invasive species are causing what some deem the sixth mass extinction. For some perspective on what it takes for a period to qualify as a mass extinction, the most recent one wiped out the dinosaurs 66 million years ago. A report released in May 2019 by the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services announced that around 1 million species, or 12.5 percent of all world species, are currently at risk of extinction. It’s natural for some species to die out every now and then, but the current extinction rate is tens or even hundreds of times as great as what the average rate has been for the past 10 million years.</p><p>Even though the planet has some natural defense mechanisms in place — such as ridding the atmosphere of excess carbon dioxide, fixing ozone holes, and allowing life to endure through adaptation — it’s hard to believe these protective measures have a chance against the speed and magnitude of our damage.</p><p>Basically, we are making the world less habitable for ourselves. Through pollution, mankind has caused climate change, which increases violent weather events and thus natural disasters. This hurts people both directly, by killing them, and indirectly, by disrupting economies. Additionally, climate change may improve conditions for infectious diseases to spread through animal vectors to humans. And, of course, people are disrupting natural ecosystems and polluting food and water supplies. On top of this, man-made health issues such as cancers and cardiovascular problems are on the rise in part because of pollution, less active lifestyles, and unhealthy diets.</p><blockquote>Even though the planet has some natural defense mechanisms in place… it’s hard to believe these protective measures have a chance against the speed and magnitude of our damage.</blockquote><p>An optimistic view would be that the Earth has natural systems in place to reverse some of our damage. In a paper that is now close to 50 years old, using data that has aged just as much, two scientists formalized this idea with the “Gaia hypothesis.” In 1973, James Lovelock and Lynn Margulis published the paper, “Atmospheric homeostasis by and for the biosphere: The Gaia hypothesis,” in which they define “Gaia” as Earth’s entire biosphere — that is, all forms of life residing on the planet. The idea is that all living things regulate each other in such a way as to ensure each other’s survival. Lovelock and Margulis believed Gaia could regulate the chemical compositions of the atmosphere, ocean, and soil; the surface temperature; and the pH of the oceans and land. It’s true that in 1973, when the paper was published, these factors had remained largely stable. But since then, all of them have, in fact, fluctuated — largely due to human actions.</p><p>Taking into account what has changed in the past half-century, climate scientist Timothy Lenton and anthropologist and sociologist Bruno Latour published a paper in 2018 arguing that Gaia gives humanity too passive of a role in maintaining the order of the natural world. Rather, they advocate for taking lessons from Gaia’s foundational principle — that all species rely on one another — to create a new framework by which we can restore the damage we’ve done. They call this framework Gaia 2.0, and in it they explain that we need to engineer more closed-material systems in which we use sustainable energy to power turning waste materials into useful products, among other strategies. Lenton and Latour also underscore the importance of designing better sensors to measure climate change and better models to effectively present climate data so that regular people, activists, and politicians can begin to enact real change on the environmental front. By building off an originally idealistic hypothesis to create realistic strategies and goals, perhaps this framework has the potential to do some real good and finally stop humanity’s reign of terror on Earth.</p><p><em>Tellus </em>(1973). DOI: 10.3402/tellusa.v26i1–2.9731</p><p><em>Science</em> (2016). DOI: 10.1126/science.aad2622</p><p><em>Science </em>(2018). DOI: 10.1126/science.aau0427</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=149c1bed1f5f" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/ecological-boomerang-how-man-made-climate-change-is-biting-back-149c1bed1f5f">Ecological boomerang: How man-made climate change is biting back</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Paws-itively essential: The psychological benefits of pets and protecting them from COVID-19]]></title>
            <link>https://medium.com/nusci/paws-itively-essential-the-psychological-benefits-of-pets-and-protecting-them-from-covid-19-9a00583e460a?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/9a00583e460a</guid>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[pets]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[neuroscience]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Thu, 20 Aug 2020 16:43:35 GMT</pubDate>
            <atom:updated>2020-08-20T16:43:35.301Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Rachel Lines, Behavioral Neuroscience, 2023</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*2cnkWCFl_G8EQBjw.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>Animals have long provided assistance to humans in times of great need. Countless heroic animals have saved human lives — dogs can undergo training to track missing persons, detect an oncoming seizure, or alert humans to mines underground. During the COVID-19 pandemic, animals continue to impact human lives (beyond interrupting Zoom calls). As knowledge about COVID-19 becomes clearer, it may be important to protect domestic animals just as we protect our immediate households. Domestic animals may also be saving lives in an unexpected way — by providing key support to mental health.</p><p>A study by Dr. Helen Brooks and her colleagues from the University of Manchester evaluated the role that domesticated animals can play in human social networks. Participants in this study were diagnosed with long-term mental illnesses and were under the care of community-based mental health services. The researchers used semi-structured interviews to collect information regarding the roles of individuals in a person’s social network with respect to the subject’s mental health management.</p><blockquote>Domestic animals may also be saving lives in an unexpected way — by providing key support to mental health.</blockquote><p>In the majority of study participants, individuals placed pets in the central, most important circle of their social network. Through qualitative surveys, the participants described their relationship with their pets as “the only thing that stayed constant,” and researchers found that participants valued “a sense of enduring trust” between themselves and their companion animals.</p><p>Additionally, pet care established an important routine that provided study participants with a responsibility that “[felt] vital for their wellbeing.” The sample used in this survey had high levels of unemployment and isolation, and participants had few similar opportunities to experience the pride associated with caring for a well-loved pet. One participant remarked that caring for the animals impacted her confidence, and another found it helped them present themselves in a more positive light. Overall, Dr. Brooks and colleagues found that pets should be considered as a main source of support in the management of mental health problems.</p><p>Other studies have also demonstrated animals’ psychological and physiological effects on humans. Animal interactions have resulted in beneficial effects for psychiatric inpatient populations through Animal Assisted Therapy (AAT). Additionally, animal interactions can have biochemical effects on humans. Researchers found that a single session of animal-assisted activity can increase immunoglobulin A, an antibody that plays a crucial role in the immune function of mucous membranes. Furthermore, a familiar pet can exhibit measurable relaxing effects on an individual, including lowered heart rate variability, decreased psychological stress, and deactivation of the middle frontal lobe, putamen, and thalamus regions of the brain. These regions are involved in executive function and reward systems.</p><blockquote>Dr. Brooks and colleagues found that pets should be considered as a main source of support in the management of mental health problems.</blockquote><p>How can pets provide these physiological and psychological benefits and intimate social connections? What makes our connection to our animals so great?</p><p>A team of researchers, including Sara Hayama and colleagues of the University of Hawaii, sought to begin answering these questions. Anthrozoological neuroscience, a term proposed by this research team, refers to the use of neuroscience techniques to study human-animal interaction and elucidate the mechanisms that may underlie the health effects of these interactions. The team used functional MRI procedures to view and analyze the brain responses of self-identified “pet owners” and “non-pet owners” while viewing animal images. Questionnaires were also administered to evaluate the conceptual attraction and attachment to different animal species.</p><p>Researchers found that pet owners experienced greater neural activation in the parietal and occipital regions of their brain when they reported greater attachment to their pet. Furthermore, activity in the posterior cingulate region of the brain had the most significant correlation to the attraction score given by participants for images of animals. This region is consistently involved in visual attention, recognition, and familiarity. Altogether, Hayama and colleagues noted that the modulation of human perception of companion animal photographs varied because of self-identification with pet ownership, the attraction to different animal species, and attachment to pets. This finding is a foundation for understanding how human-animal interactions can have health effects.</p><blockquote>The World Organization for Animal Health has stated that the spread of COVID-19 is a result of human-to-human transmission, but dogs and cats (domestic and large) have tested positive for the disease following close contact with humans.</blockquote><p>Pets have been shown to provide many benefits to their owners. Since they are so highly valued, an emerging fear among pet owners has become the safety of their animal companions amid the coronavirus pandemic. The World Organization for Animal Health has stated that the spread of COVID-19 is a result of human-to-human transmission, but dogs and cats (domestic and large) have tested positive for the disease following close contact with humans. Further studies are necessary to better understand the susceptibility of domestic animals. However, restricting pets from interactions with other people and animals from different households could help stem the spread of COVID-19 among pets and their human caretakers.</p><p>Protecting domestic animals is important to help prevent further spread of COVID-19. But even beyond being possible vehicles for disease transmission, domestic animals play a larger role in human lives. Pets have been shown to have central roles in human social circles and have psychologically and physiologically beneficial effects. Resulting from the COVID-19 pandemic, adoption numbers and fostering of pets has dramatically increased. Beyond protecting these domestic animals from disease, humans may be benefitting significantly from these new bonds.</p><p><em>BMC Psychiatry</em> (2016). DOI: 10.1186/s12888–016–1111–3</p><p><em>Neuropsychologia</em> (2016). DOI: 10.1016/j.neuropsychologia.2016.03.018</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9a00583e460a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/paws-itively-essential-the-psychological-benefits-of-pets-and-protecting-them-from-covid-19-9a00583e460a">Paws-itively essential: The psychological benefits of pets and protecting them from COVID-19</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Room to breathe: Reinventing urban design to withstand future pandemics]]></title>
            <link>https://medium.com/nusci/room-to-breathe-reinventing-urban-design-to-withstand-future-pandemics-21a627cb2ff9?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/21a627cb2ff9</guid>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[world]]></category>
            <category><![CDATA[urban-planning]]></category>
            <category><![CDATA[pandemic]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Wed, 19 Aug 2020 16:50:38 GMT</pubDate>
            <atom:updated>2020-08-19T16:50:38.601Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Annabelle Mathers, Civil Engineering, 2022</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*x9Tnzs79IcDCldG1.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>The idea of transforming cities into ideal, or even relatively effective, urban spaces that accommodate physical distancing and large fluctuations in public behavior can seem overwhelming, especially in the tumultuous wake of the COVID-19 pandemic. This task, as a whole, is enormous on an economic, political, and social level, with an innumerable amount of moving parts and complex factors. Fortunately, urban planners, engineers, and architects are working to develop cost-conscious changes that make cities more flexible and functionally dynamic in preparation for future times of great sickness. It may not presently be possible to create components of a city that completely prevent viral transmission; however, this effort may decrease transmission and urban shutdowns, improve quarantine experiences, and accelerate societal recovery.</p><p>Across different countries, climates, and local cultures, the priorities of urban inhabitants differ. Thus, there may be widely nuanced applications of solutions pertaining to common areas of concern including offices, environmental psychology, infrastructure, and communal public spaces. Ongoing research now attempts to consider and mull these evolving factors as the wait continues for more consistent statistical analysis. Fear, harbored by a more wary public, now challenges trends like open-concept offices, high density infrastructure, and community spaces that encourage physical interaction. Instead of creating spaces that perpetually enforce social and physical distancing, society may work toward facilitating spaces that are, whenever necessary, creatively flexible enough to accommodate varying degrees of societal change without complete separation and shutdown.</p><blockquote>Instead of creating spaces that perpetually enforce social and physical distancing, society may work toward facilitating spaces that are, whenever necessary, creatively flexible enough to accommodate varying degrees of societal change without complete separation and shutdown.</blockquote><p>This transitional concept of urban design allows the public to weigh the risks and rewards with societal changes and expenditures, and can be applied toward epidemics of different severities and characteristics. Public health must be maintained; however, the drastic application of rigid lifestyle changes and physical distancing in perpetuity has already pushed people to reevaluate the balance of risk and reward. Urban improvements have to consider this sense of realism, while also envisioning an ingenuitive society beyond its current state. Private homes and spaces highlight the smaller, and realistically easier changes that may still be relatively important to individuals.</p><p>Environmental psychology, in particular, permeates the boundaries of public and private spaces. This term refers to the study of the way in which the surrounding world, mostly built and natural environments in this application, affects mental wellbeing. With the lines blurred between work and home during quarantine, the uncomfortable physical and mental confines of homemade office spaces, and rooms in general, are more apparent. In other words, the spatial chaos of quarantine may distort spatial associations and comforts held by the average person. Adaptive spaces in homes are especially helpful for remote workers, where multifunctional rooms and interior setups enable individuals to more comfortably reallocate space for work and leisure.</p><blockquote>Urban improvements have to consider this sense of realism, while also envisioning an ingenuitive society beyond its current state.</blockquote><p>Public office spaces may also need to question and reorganize spaces and priorities for meetings, cubicles, foot traffic, and shared spaces like kitchens. Offices that lack private, distanced workspaces, and that encourage a high degree of collaboration in shared spaces, now may consider temporary strategies for a more independent, spatially restrictive work environment. Although not every existing office can be retrofitted to become perfectly flexible in terms of physical spaces, it is the general open-mindedness toward preparation and adaptation that may be beneficial.</p><p>Additional questions arise regarding whether reinvigorated appreciation for outdoor spaces and spacious interiors will affect architectural design of urban homes that lack the backyards and square-footage of suburban ones. A desire for rooftop and urban gardens, windows, and natural light in homes has the potential to grow considering the burden that a tiny apartment may place on mental health during quarantine. This increase in appreciation for biophilic design in homes (not to mention public office spaces) may also include green walls, water features, and house plants. As architects experiment more with incorporating aquatic and plant-based feature walls into the average home to improve aesthetics and even for eco-friendly purposes, the application to the average household will hopefully become more realistic and manageable.</p><p>Likewise, appreciation for natural surroundings may extend to redesigned public spaces involving parks, recreational space, and pedestrian amenities. How long this newfound fascination with outdoor spaces may last is unclear, but the reconfiguration of parks can be a long-lasting, multi-purposeful, and comparatively low-cost way to boost public morale and safety. For example, complex park walkways created from maze-like hedges envisioned by Precht, an Austrian studio, emphasize the sudden desire for individual exercise space and variety. Larger, open spaces may become more flexible toward greater compartmentalization and expansion for concentrated activities and field hospitals respectively. Furthermore, smaller pockets of greenery in denser residential areas may gain greater purpose and alleviate the attendance burden on central spaces. More spatially dynamic and resilient cities may incorporate greenspace with variety and prevalence all throughout the urban area, thus reducing the need for extreme emphasis on centralized amenities.</p><blockquote>More spatially dynamic and resilient cities may incorporate greenspace with variety and prevalence all throughout the urban area, thus reducing the need for extreme emphasis on centralized amenities.</blockquote><p>Discussion of pedestrian changes also demands changes in public transportation. Increased attention toward bicycles and cars further complicates the typical commuter patterns during and after physical distancing measures. Again, experts must consider the question of whether or not bicyclists will truly remain prominent in areas of inconvenient climate, roadways, and lifestyles. Major cities within Scandanavian countries, the United States (e.g. Boston, New York City), Latin American, and other areas of the world continue to experiment with closed roads, enhanced bicycle lanes, and widened sidewalks. Because transportation infrastructure is one of the most expensive undertakings, efforts focus on retrofitting existing facilities and tactical application of changes to key areas of cities for the utmost beneficial output.</p><p>Keeping an open mind toward traffic flow may generally help city officials plan for large fluctuations in commuters, curbside parking, and delivery services. In light of these changes, use of public transportation, notably in the form of trains and buses, often decreases severely, with the potential to suffer long-term distrust from a spatially-wary public. Preplanned sanitation services and strategic dispersal and time management are retrofit alternatives to completely rebuilding interiors originally meant to maximize capacity. The losses to public transportation may be inevitable, especially with the transition to remote work, but utilizing this hindsight in the future may allow cities to reduce the amount of resources wasted in the early stages of quarantine.</p><blockquote>Urban density is a major component of urban design, but the dynamics of such patterns, especially with respect to sickness, can be difficult to define under statistics and trends. Simply relating urban density to transmission rates is a tricky task.</blockquote><p>Finally, urban density is a major component of urban design, but the dynamics of such patterns, especially with respect to sickness, can be difficult to define under statistics and trends. Simply relating urban density to transmission rates is a tricky task. However, extremely crowded venues and housing developments continue to undergo increased scrutiny during viral outbreaks in major cities. Whether or not there is a future migration to suburban areas by disenchanted urbanites, addressing density is made more difficult by the upward growth of cities. Many of the aforementioned topics already address micro-level issues caused by density. Until macro-level changes can be applied to discrete, planned concentrations of housing organization and businesses, smaller urban remedies can take on a broader variety of forms across different cities.</p><p>It is unknown exactly how much impact the current pandemic will have on the perception and implementation of urban life, as retrospect may eventually lead to more practical, less reflexive analysis of the situation. Conflicting research results among a wide variety of pandemic-related topics further complicates the response of urban planners and architects. Solutions ideally contain enough foresight to also accommodate changes in populations and standards of living over time. Human society is admirably resilient and often quick to return to habits, but the chance to prevent future combinations of economic and health disasters, regardless of how COVID-19 progresses, may serve as motivation to take a practical and preemptive step toward a more flexible, and ultimately even more resilient society.</p><p><em>OSF Preprints</em> (2020). DOI: 10.31219/osf.io/rf7xa</p><p><em>Emerald Open Research</em> (2020). DOI: 10.35241/emeraldopenres.13561.1</p><p><em>KnE Engineering</em> (2017). DOI: 10.18502/keg.v2i2.596</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=21a627cb2ff9" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/room-to-breathe-reinventing-urban-design-to-withstand-future-pandemics-21a627cb2ff9">Room to breathe: Reinventing urban design to withstand future pandemics</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The role of mucins in disease transmission]]></title>
            <link>https://medium.com/nusci/the-role-of-mucins-in-disease-transmission-b51358806c65?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/b51358806c65</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[biology]]></category>
            <category><![CDATA[covid19]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Tue, 18 Aug 2020 02:40:45 GMT</pubDate>
            <atom:updated>2020-08-18T02:40:45.261Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Ryan Brady, Chemical Engineering &amp; Biochemistry, 2022</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*qw0quw7UZ3RjFmfm.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>The body is a well-designed system with a variety of barriers to keep invaders out. These range from the physical barriers of the skin to the biological protection of the immune system. However, the structures of the face such as the eyes, nose, and mouth represent major vulnerabilities. The nose and mouth are an interconnected system in which saliva and mucus serve as the physical barriers to keep viruses and other contaminants out. Coughing and sneezing are effective means of keeping viruses and other foreign material out of the body by expelling these invaders into the environment. These expulsions create small particles of liquid which travel through the air, potentially infecting others with the virus.</p><p>One MIT study was conducted this year and demonstrated the potential impact of coughing and sneezing on disease transmission. The researchers generated a number of visualizations of the small liquid particles that are generated. These visualizations show that the particles gathered in clouds up to 27 feet from the original expulsion. Physical barriers such as masks can help to minimize the size of the emulsions and decrease the potential for viral transfer. This demonstrates the need for masks in public and the need for social distancing to prevent the direct transfer of these particles. However, another means of transmission is the deposition of these droplets onto surfaces.</p><p>The analog to this MIT study is an early publication in <em>The New England Journal of Medicine</em> from earlier in 2020, which attempted to assess the survivability of the aerosolized virus on surfaces. It identified that the virus could potentially survive up to 72 hours on plastics and stainless steel. However both this and the MIT study represent preliminary findings which fail to fully capture the phenomena occurring. Both studies simplified the chemistry of these droplets to aqueous solutions. In reality, these droplets contain a number of biochemical compounds and cells which could potentially impact the survivability of the virus. One of the compounds that directly interacts with the virus are mucins.</p><blockquote>These droplets contain a number of biochemical compounds and cells which could potentially impact the survivability of the virus.</blockquote><p>Mucins are a specialized type of protein designed to form chemical barriers in epithelial tissues. There are up to 20 different types, but all of them fall into the class of glycoproteins. Glycoproteins consist of proteins that are covalently linked to carbohydrates. For mucins, the proteins serve as a sort of a molecular backbone, off of which numerous carbohydrates are linked. These carbohydrates form chains off of the protein to create a matrix of said chains. This matrix provides the functional relevance of these molecules, allowing large molecules to get stuck within it. These proteins can be either membrane-bound or secreted out of cells to form a gel layer. This gel layer is part of the epithelial lining. As part of the lining it will be present in the throat and nasal cavities and can therefore be expelled as part of a sneeze or cough.</p><p>One particular mucin is present in high proportions in the mouth: MUC5B. This mucin is most likely to be present in the particles expelled via coughing and sneezing. It has been shown to decrease the amount of bacteria and fungal infections in that area. This is related to the spread of diseases because the particles expelled from the body contain these mucins, which can impact the survivability of particles outside the body. While this represents one of the mucins, a variety of mucins can be present, and the actual composition varies from person to person based on both genetic and environmental factors.</p><blockquote>One particular mucin is present in high proportions in the mouth: MUC5B. This mucin is most likely to be present in the particles expelled via coughing and sneezing.</blockquote><p>Cutting-edge research, led by Dr. Jessica Kramer at the University of Utah, is working to model these interactions and quantify their impact on viral survivability. Her lab focuses on the synthetic production of mucins with a long term application in a variety of clinical spaces. With the onset of COVID-19, the lab received funding from the National Science Foundation to test its viral stability in solution with the synthetic mucins. These results will help to better understand how the virus exists in the environment and could inform public health guidelines that are essential to societal function.</p><p><em>Applied and Environmental Microbiology </em>(2015). DOI: 10.1128/AEM.02573–14</p><p><em>JAMA </em>(2020). DOI:10.1001/jama.2020.4756</p><p><em>The New England Journal of Medicine </em>(2020). DOI: 10.1056/NEJMc2004973</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b51358806c65" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/the-role-of-mucins-in-disease-transmission-b51358806c65">The role of mucins in disease transmission</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Two sides of the coin: Boston biotech’s role in COVID-19]]></title>
            <link>https://medium.com/nusci/two-sides-of-the-coin-boston-biotechs-role-in-covid-19-8dfe49547153?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/8dfe49547153</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[biology]]></category>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[boston]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Sun, 16 Aug 2020 18:55:04 GMT</pubDate>
            <atom:updated>2020-08-16T18:55:04.532Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Gabrielle Hernandez, Biochemistry, 2023</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*KpqOH-iowC4OE4wV.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>Boston takes pride in being one of the scientific research capitals of the world. With some of the most prestigious universities funneling students and professors alike into small start-ups in Kendall Square and Seaport, Bostonian biotechnology has blossomed into a multi-billion dollar industry. At Northeastern University, the biotech industry has provided thousands of cooperative education opportunities to STEM students, allowing undergraduates to observe how research is conducted in industry versus academia. Furthermore, students witness the great innovations that arise out of Boston’s biotech field, such as Vertex Pharmaceuticals’ small-molecule therapies for cystic fibrosis, or Pfizer’s vaccine developments to fight infectious disease. However, as with any field, there are two sides to Boston’s gold coin.</p><p>In early February, the majority of American citizens went about their daily lives unaware of a worldwide shift that would take place in just over a month and push most of the population to shut their doors to the outside world for weeks on end. This was true for most of Boston as well. Only one confirmed case of SARS-CoV-2, better known as COVID-19 — the disease caused by this novel strain of coronavirus, existed in the state. This case involved a student who had returned to the University of Massachusetts Boston from his home in Wuhan, China, the original epicenter of the virus. He stayed in quarantine — all of his interactions contact-mapped with the precision expected of a scientific and medical capital. There was little reason for panic, although, COVID-19 was silently spreading throughout the country.</p><p>This all drastically shifted when a meeting of 175 executive employees from the biotech company, Biogen, met at a hotel in downtown Boston. Employees gathered from across the United States and the world and, unbeknownst to them, carried the virus across the nation. As of now, the CDC states that it can take up to 14 days to experience first symptoms after exposure to the virus, so many employees attended the conference initially feeling completely healthy, only to realize they carried the coronavirus days later. Since then, experts have traced the Biogen conference as the cause of early cases in North Carolina and the first cases in both Indiana and Tennessee. The Massachusetts Department of Health initially linked 99 cases back to the original meeting, which experts then termed a “super-spreader” event, or a moment of high transmission that leads to a greater spread of disease.</p><blockquote>Although the Biogen event caused many of the early cases in Massachusetts (and elsewhere), Boston biotech is also playing a large part in the race to produce accurate, widespread testing systems and a vaccine.</blockquote><p>Although the Biogen event caused many of the early cases in Massachusetts (and elsewhere), Boston biotech is also playing a large part in the race to produce accurate, widespread testing systems and a vaccine. E25bio, a two-year-old start-up company that grew out of the Massachusetts Institute of Technology, quickly stepped up to develop cheap and easy COVID-19 tests. The company is a good fit for the task too — they have experience in designing rapid antigen tests for Zika and dengue. Through innovative methods that include mobile image capture and image processing through new computer software, they remove subjectivity and time limits that are characteristic of these tests. By February 26th, the tests could already produce results in 15 minutes, and they provided a visual indicator of whether or not the patient has ever had COVID-19. Although this seems promising, antigen tests have a disastrous history of testing efficacy. The sensitivity of most antigen tests ranges from 50 percent to 90 percent, indicating that, in nearly half of cases, the tests can be wrong. Nevertheless, E25bio now awaits FDA approval to begin testing.</p><p>Despite the questionable nature of the development of antibody and antigen tests, one Boston biotech company spells hope for the world in the form of a future vaccine. Moderna, a start-up known for its mRNA-based therapies, produced promising Phase 1 results for its COVID-19 vaccine, mRNA-1273. With this, the Food and Drug Administration gave Moderna permission to begin Phase 2 trials, which will grow the study from eight participants using two different dosages to 600 participants using multiple dosages. Moderna also announced protocols for Phase 3, which includes 30,000 subjects, each tested with a 100-microgram dose starting in July 2020. Experts chose this particular dose based on the results of Phase 1, which showed it to be the best balance between immune response and side-effects of the treatment.</p><p>The nucleic acid vaccine created by Moderna produces proteins from mRNA codes that cause your body to prepare antigens for the proteins associated with the virus. When infected again, your body reacts as if it has already had the virus. The mRNA in this vaccine codes for the spiky protein located on the outside of the COVID-19 virus, the protein that causes infection in the first place.</p><blockquote>This delivery technology is relatively new, so as Moderna continues development on this vaccine they will be cashing in on a revolutionary form of vaccine development.</blockquote><p>A drawback of RNA-based therapies is that RNA is notorious for its instability and degradability, leaving many vaccines useless without a proper way of delivering it into the body. Successful delivery vectors, or modes of transportation for the vaccine material, must be small and as safe as the vaccine itself. For mRNA-1273, the vaccine uses novel lipid nanoparticles, which allow for intracellular delivery of the unstable mRNA. The vector creates fatty armor around the mRNA to protect it from degradation, and it can migrate into cells through endocytosis, a natural function of the cell membrane, by expunging toxins and absorbing nutrients into cells. Back in 2016, reviews of this method mentioned limitations in the lack of knowledge surrounding the mechanisms of lipid nanoparticles that allow them to cross membranes, but it seems as though Moderna cracked the code for COVID-19. This delivery technology is relatively new, so as Moderna continues development on this vaccine they will be cashing in on a revolutionary form of vaccine development. It is important to note, however, that Moderna has yet to bring a drug to market even before the pandemic.</p><p>These are just two examples of companies, within Boston’s vast biotechnical industry, willing and ready to take on the unknowns of a virus that continues to change the world. Nevertheless, it is important to recognize the role that the industry plays on both sides of this pandemic. Ultimately, it represents the intertwined nature of the Boston community and biotechnical business, and how that relationship will construct the city’s future.</p><p><em>medRxiv</em> (2020). DOI: 10.1101/2020.05.24.20112110</p><p><em>Science Translational Medicine </em>(2017). DOI: 10.1126/scitranslmed.aan1589</p><p><em>Science </em>(2020). DOI: 10.1126/science.abc9586</p><p><em>Therapeutic Delivery </em>(2016). DOI: 10.4155/tde-2016–0006</p><p><em>RNA Biology </em>(2012). DOI: 10.4161/rna.22269</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8dfe49547153" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/two-sides-of-the-coin-boston-biotechs-role-in-covid-19-8dfe49547153">Two sides of the coin: Boston biotech’s role in COVID-19</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Contact tracing and privacy]]></title>
            <link>https://medium.com/nusci/contact-tracing-and-privacy-c25bfba64aa3?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/c25bfba64aa3</guid>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[data]]></category>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[covid19]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Sun, 16 Aug 2020 18:31:51 GMT</pubDate>
            <atom:updated>2020-08-16T18:31:51.499Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Sanjana Mishra, Computer Science, 2023</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*7_gophf8mydc7x4G.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>If COVID-19 has improved one skill of the masses other than bread baking, it’s recognizing people without their face. From six feet away with masks covering most of their faces, people have now become recognizable by their mannerisms, clothing choices and occasionally (if you can hear them through their masks) their voices. Not being able to hug family members or friends, shake hands, or conduct meetings in person has become a nuisance to our daily lives. Humans are social creatures, but it has been almost three months since our definition of social interaction was flipped on its head. As we endure “pandemic-fatigue,” the nation, along with the rest of the world, is looking for a way to open up safely. We’ve flattened the curve, but how do we keep it that way? Many have their eyes on contact tracing apps.</p><p>According to Crystal Watson, a senior scholar with the John Hopkins Center for Health Security, contact tracing is “the best tool we have to manage [COVID-19] in an ongoing way and allow our economy to open up again.” Tech giants Apple and Google have partnered to make it easier for these apps to hit their respective app stores sooner rather than later. The plan is for the app to monitor our locations and interactions for 14 days. If we get tested for COVID-19 and the results are positive, the app will alert those who have come in contact with us and advise them to isolate as well. The noble goal behind these apps is unmistakable, but citizens still question, “What about privacy?” Many users fear their data will be leaked and feel uncomfortable with the idea of carrying around a smartphone all day with certain settings turned on to specifically track their locations and interactions.</p><blockquote>Privacy software maker Jumbo discovered that Care19 was violating its own privacy policy by sharing citizen data location and other personal information with Foursquare, a data provider for marketers.</blockquote><p>Contact tracing apps bring the constant battle between convenience and privacy to the forefront. If we look to North and South Dakota, we can get a better sense of just how complicated the tracking aspect of these apps can be. These two states released a contact tracing app, Care19, that was supposed to help with the reopening process. Both state officials and Apple were responsible for vetting the app before it was released for public use, but privacy software maker Jumbo discovered that Care19 was violating its own privacy policy by sharing citizen data location and other personal information with Foursquare, a data provider for marketers. While Foursquare alleges that the data was never used, companies could take advantage of future data.</p><p>To combat the very concerns that were exacerbated with Care19, Apple and Google are utilizing Bluetooth technology to ease security concerns. Bluetooth’s low-energy specification for broadcasting short bursts of data allows smartphones to emit a random string of characters, which we refer to as a key, that acts as an alias to other devices. The key is changed every 10 to 20 minutes to ensure that connecting data to a specific individual is nearly impossible for third parties. While the key is being shared with other devices, the smartphone records other incoming keys as well. This system allows an individual who tests positive for COVID-19 to anonymously alert those they have come in contact or interacted with.</p><blockquote>Bluetooth’s low-energy specification for broadcasting short bursts of data allows smartphones to emit a random string of characters, which we refer to as a key, that acts as an alias to other devices.</blockquote><p>Even with this updated system, many Americans are put off by installing apps that can monitor them and instruct them on how to live. A study of about 800 Americans conducted by Microsoft Research, Johns Hopkins University, and the University of Zurich showed that eagerness to install these contact tracing apps was dependent on the app’s accuracy and ability to protect personal information. Specifically, Americans cared about how accurate the app was at detecting false positives. Researchers found that people didn’t want to be told they should isolate for 14 days if they weren’t seriously exposed and were only in the vicinity of an infected individual. Already uncomfortable with potential privacy loss, many Americans are not looking to give up that information in exchange for threats of unlikely infection. Beyond just accuracy issues, there are concerns that contact tracing apps, if adopted, will desensitize the general public to privacy violations and may lead to a new status quo — one where privacy is not a concern at all. Elected officials have tried to quell these fears through legislation, bringing forward the Public Health Emergency Privacy Act and COVID-19 Consumer Data Protection Act of 2020. The former looks to ensure that organizations save, use, and disclose necessary data while preventing discrimination based on the data collected. Similarly, the latter establishes that companies disclose how data will be collected and where it will be going. It requires organizations to allow individuals to opt out of collection, handling, and transfer of their data. Both pieces of legislation protect consumers by putting forward temporary regulations regarding the accumulation and propagation of emergency health data, but do little to quell privacy fears beyond the pandemic.</p><p>At the end of the day, contact tracing is inherently invasive. Regardless of the rules, regulations, and laws in place, people may not feel comfortable downloading an app onto their device that is simply meant to monitor them. This lack of support may some cause some issues with the efficiency of the concept itself. Researchers at the University of Oxford believe that approximately 60 percent of the population would need to faithfully use the app in order for it to be truly effective. In contrast, studies found that only 4.4 percent of North Dakota residents and two percent of South Dakota residents downloaded the Care19 app and gave the app location tracking permission.</p><p>Now more than ever, consumers are more and more aware of privacy concerns and how their data is being disseminated online. This makes contact tracing apps a harder sell to the general public. While it may be for the greater good, it is a cost that many may not be willing to pay.</p><p><em>Nature </em>(2020). DOI: 10.1038/d41586–020–01514–2</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c25bfba64aa3" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/contact-tracing-and-privacy-c25bfba64aa3">Contact tracing and privacy</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Vaccine development: From the lab bench to the doctor’s office]]></title>
            <link>https://medium.com/nusci/vaccine-development-from-the-lab-bench-to-the-doctors-office-d7bffc663506?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/d7bffc663506</guid>
            <category><![CDATA[biology]]></category>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Sun, 16 Aug 2020 01:18:58 GMT</pubDate>
            <atom:updated>2020-08-16T01:18:58.915Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Cailey Denoncourt, Bioengineering, 2022</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*n8Kv89R4cnxOKLmN.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>The race to develop a vaccine for the ongoing COVID-19 pandemic spans across the world as the virus continues to take thousands of lives every day. Unfortunately, the fastest vaccines typically take at least five years to fully develop; this includes multiple failed attempts before commercializing an effective vaccine that successfully passes all clinical trials and safety guidelines. As businesses start to reopen across the country and social distancing guidelines continue to be ignored, infection rates coming into Fourth of July weekend are at an all time high. With another wave expected later this year, the rapid development of a vaccine could save thousands of lives.</p><p>In order to fully understand the lengthy vaccine development process, how the vaccine is able to give an individual immunity to the virus must also be understood. Vaccines are developed in order to mimic the agents of the virus, so that the immune system can build a defense system without directly experiencing the negative symptoms associated with infection.</p><p>When the virus first enters the body, an antigen presenting cell (APC) breaks down the virus and displays the antigens on its surface, which are detected by T-helper cells to alert an immune response. This response recruits two types of B cells: plasma and memory cells. Plasma B cells are antibody factories. The produced antibodies can then attach to the antigens on the virus prohibiting it from entering the cells. More critical are memory B cells, which memorize how to produce these antibodies, so the immune system can respond stronger and swifter if ever exposed to the virus again.</p><blockquote>Starting in the lab, the traditional vaccine development process begins with isolation of the virus from an affected individual, which is then grown in bioreactors and harvested for modifications.</blockquote><p>Starting in the lab, the traditional vaccine development process begins with isolation of the virus from an affected individual, which is then grown in bioreactors and harvested for modifications. These modifications can range widely based on the virus and can include weakening, inactivating, or removing a portion of the virus so that an immune response is still activated with no symptoms.</p><p>Since a vaccine requires injecting parts or the entire virus into the patient, there are multiple safety guidelines that are regulated by the Center for Biologics Evaluation and Research. Once a vaccine candidate has been developed, it undergoes a series of preclinical trials, which must prove its effectiveness and safety before moving onto clinical trials. The three stages of clinical trials allow the companies to evaluate the safety and effectiveness directly in humans, while also determining the correct dosage and possible side effects. On top of ensuring the vaccine is safe and effective, manufacturing development is equally important in order to ensure that the commercialization of the vaccine is able to support distribution to a large population.</p><blockquote>The three stages of clinical trials allow the companies to evaluate the safety and effectiveness directly in humans, while also determining the correct dosage and possible side effects.</blockquote><p>This is a very extensive, time-consuming process that would take extremely long to complete during the current pandemic. Thus, during an outbreak, this timeline is often accelerated by overlapping the pre-clinical, clinical, and manufacturing phases. During a public health emergency, the FDA is allowed to authorize emergency-use potentially before all the usual bars have been met. This, combined with compressing the timeline, is leaving the public with many reservations. Even with the possibility of record breaking release, as companies continue to push the regulation limits, the vaccine may not be as widely accepted or effective as needed to stop the spread.</p><p>As of early April 2020, there are about 115 vaccine candidates in development across the globe. The most advanced candidate being the mRNA-1273 from Moderna, which was developed at a record pace of 42 days. This was possible with a newer variety of vaccines that do not involve directly injecting the virus into the patients. Similarly to the traditional process, the virus is isolated from an infected individual. However, instead of direct injection, Moderna uses mRNA. It encodes for the instructions on how to make the spike protein, a necessary agent of the COVID-19 virus that allows it to invade cells. The mRNA is taken in by APCs in the immune system, and they are able to directly use the mRNA to produce the protein with the components they’re already equipped with. The development of RNA vaccines are becoming more common because of shorter manufacturing times and easier antigen manipulation, so although no mRNA vaccines are available to date, their popularity is expected to increase in the future.</p><p>As Moderna starts to move into Phase 2 of clinical trials and prepares for Phase 3 in July 2020, the potential to have a vaccine for emergency use in 2021 seems hopeful. However, if the vaccine continues to pass all the development stages, the collaboration between companies, manufacturing plants, and governments around the world will be essential for its quick production and delivery to all affected regions.</p><p>Although the wide distribution of a vaccine to the general public is still far out, the rapid development of such an advanced candidate in this timeframe is a feat that truly displays the power and advancement of the biotech industry.</p><p><em>The New England Journal of Medicine</em> (2020). DOI: 10.1056/NEJMp2005630</p><p><em>Nature</em> (2020). DOI: 10.1038/d41573–020–00073–5</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d7bffc663506" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/vaccine-development-from-the-lab-bench-to-the-doctors-office-d7bffc663506">Vaccine development: From the lab bench to the doctor’s office</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why are hospitals losing money during a pandemic?]]></title>
            <link>https://medium.com/nusci/why-are-hospitals-losing-money-during-a-pandemic-e6384103e0f7?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/e6384103e0f7</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[covid19]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Sun, 16 Aug 2020 01:09:56 GMT</pubDate>
            <atom:updated>2020-08-16T01:09:56.457Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Jason Denoncourt, Chemical Engineering, 2023</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*v7z_cb3yUgqd5FEX.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>With cases surpassing two million nationwide, hospitals and healthcare systems across the country have stepped up to meet the unprecedented challenges of COVID-19. Doctors, nurses, and other healthcare workers courageously serve those weakest while risking it all — reusing personal protective equipment (PPE), taking up additional shifts, and often living in hotels or garages in fear of infecting loved ones.</p><p>Despite often filling beyond capacity and providing thousands of tests daily, U.S. hospitals are losing an estimated $50.7 billion per month, according to the American Hospital Association (AHA). While hospital revenue has sharply declined since the start of the pandemic, hospital expenses have dramatically sky-rocketed.</p><blockquote>Before the pandemic, many hospitals, particularly independent and rural hospitals, were already losing money.</blockquote><p>As the pandemic spread, governors across the country quickly mandated the indefinite cancellation and delay of all elective operations and procedures. Though these swift actions improved public safety by preventing unnecessary contact while simultaneously preserving PPE, they’ve directly resulted in immediate and widespread financial distress among hospitals. Before the pandemic, many hospitals, particularly independent and rural hospitals, were already losing money. According to the AHA, about 23 percent of hospitals in the United States lost money in 2015. The pandemic has only exacerbated the financial fragility of hospitals caused by a flawed business model.</p><p>The financial success of most hospitals heavily relies on providing elective, well-reimbursed procedures, like orthopedic surgeries and radiological scans, to privately insured patients. Conversely, patients covered only by public insurance, like Medicare and Medicaid, cost hospitals $57.8 billion per non-pandemic year, according to the AHA. Furthermore, hospitals lose additional money by providing uncompensated care for those uninsured. Now, with nearly all healthcare resources committed to COVID-19 treatment, the business model of hospitals is evidently failing during these unprecedented times.</p><blockquote>The financial success of most hospitals heavily relies on providing elective, well-reimbursed procedures, like orthopedic surgeries and radiological scans, to privately insured patients.</blockquote><p>At-risk populations, primarily the elderly and people with underlying conditions, have significantly higher COVID-19 hospitalization rates. Minority groups face disproportionately higher rates of COVID-19 infection and death. In a recent Centers for Disease Control and Prevention (CDC) report, 33 percent of hospitalized patients were Black, compared to only 18 percent in the greater community. Ultimately, these groups are more likely to be on public insurance, like Medicaid, or uninsured. According to the CDC, Hispanics/Latinxs are nearly three times more likely to be uninsured compared to white people and Black people nearly twice as likely compared to whites. These numbers present financial challenges for hospitals, as the surge in uninsured or underinsured Americans seeking medical attention applies yet another strain on the already fragile healthcare system.</p><p>With hospitals receiving less from public insurance than the cost of treatment and little to no money from the uninsured, hospitals are forced to take the financial burden as more are hospitalized. To put it in perspective, the Kaiser Family Foundation estimates the cost of treating a COVID-19 patient often exceeds $20,000. It can even extend up to $88,000 for patients that need ventilator support. Moreover, with unemployment rates nearing 15 percent as of April 2020, many American families have lost insurance provided by their companies, further increasing the amount of uncompensated care at hospitals. Compared to March of 2019, charity treatment has risen about 13 percent in 2020, according to a recent study from Kaufman Hall.</p><blockquote>Though the cancellation of elective procedures has helped to preserve the limited supply of PPE, healthcare workers have still ultimately been forced to reuse N95 masks or resort to the lovingly-sewed, but less effective, homemade masks.</blockquote><p>Though the cancellation of elective procedures has helped to preserve the limited supply of PPE, healthcare workers have still ultimately been forced to reuse N95 masks or resort to the lovingly-sewed, but less effective, homemade masks. The shortage of PPE spans the entire country. Even rural hospitals that have not seen a COVID-19 case face shortages and high prices. Gowns that cost 50 cents before the coronavirus pandemic fetched nearly $10 in peak shortage periods. Face shields costing $1.25 before the pandemic went for upwards of $25. These high prices and need for face coverings for all staff force hospitals to spend much more than budgeted for PPE.</p><p>As a result of lost revenue and rising expenses, hospitals must furlough or lay off the healthcare heroes in the midst of the pandemic. According to the US Labor Department, about 1.4 million healthcare workers lost their job in April of 2020. Furthermore, the cancellation of elective procedures at rural, independent hospitals, which have often seen very few COVID-19 cases but are burdened by rising expenses, is expected to push many perilously close to closing. Since 2010, 130 rural hospitals have closed across the country. These hospitals are critical for healthcare equity. With the pandemic only accelerating the closure of rural hospitals, some Americans could be forced to drive more than an hour to the nearest doctor, which would be catastrophic in cases of emergencies. With COVID-19 still an eminent threat in many parts of the country, this pandemic will continue to expose and exacerbate the issues of America’s fragile and inequitable healthcare system.</p><p><em>Morb Mortal Wkly Rep</em> (2020). doi.org/10.15585/mmwr.mm6915e3</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e6384103e0f7" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/why-are-hospitals-losing-money-during-a-pandemic-e6384103e0f7">Why are hospitals losing money during a pandemic?</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Low calorie or low quality?]]></title>
            <link>https://medium.com/nusci/low-calorie-or-low-quality-6cd77ee1d6a?source=rss-7d968cc5324f------2</link>
            <guid isPermaLink="false">https://medium.com/p/6cd77ee1d6a</guid>
            <category><![CDATA[biology]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[food]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[NU Sci Staff]]></dc:creator>
            <pubDate>Fri, 14 Aug 2020 00:10:59 GMT</pubDate>
            <atom:updated>2020-08-14T00:10:59.480Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Amanda Bell, Data Science &amp; Biology, 2023</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*j3RTGI8xpIYgrDIW.jpg" /><figcaption>Source: Pixabay</figcaption></figure><p>It’s well known that sugar is addictive and consuming too much of it can be a risk factor for a variety of health problems including obesity, diabetes, and cardiovascular disease. As a result, many food companies use non-nutritive sweeteners, also known as low calorie or artificial sweeteners, to replace sugar in their products. Artificial sweeteners supposedly make low calorie foods taste better, but are low calorie sweeteners really “healthier” than sugar, and what effect do they have on our bodies?</p><p>Non-nutritive sweeteners must be approved for use by the FDA in the United States, so they are supposedly safe for consumption. The reason they are so low in calories is that they are typically about 200 to 700 times sweeter than table sugar, so a significantly smaller amount of them needs to be used to achieve the same sweetness level as sugar in food. The most common artificial sweeteners include saccharin, aspartame, acesulfame potassium, and sucralose — all of which were created in laboratories. Another common non-nutritive sweetener, stevia, comes from the<em> Stevia rebaudiana</em> plant. Some of these sweeteners have caused health scares in the past. For instance, saccharin was linked to bladder cancer in rats used for research, but in human studies, it was found to be safe and noncarcinogenic. Another issue occurred with aspartame, because it contains phenylalanine, which some people with a rare hereditary disease are unable to metabolize. Although these are small incidents, it’s important that people are aware that artificial sweeteners may still have adverse health effects that haven’t been proven yet.</p><p>In a study performed at the University of Sydney, researchers assessed how sucralose, acesulfame potassium, and saccharin affect the growth of <em>E. coli</em>, a bacteria found in the intestines of humans and other animals. The researchers found that all three sweeteners inhibited the growth of <em>E. coli</em> and also reduced the size of <em>E. coli</em> colonies in petri dishes. This led the researchers to hypothesize that these artificial sweeteners may have similar effects on other intestinal bacteria. Because intestinal bacteria helps with digestion as well as food breakdown and absorption, this inhibition in the body could lead to digestive issues.</p><p>The second part of the study examined the effects of sucralose on the gut bacteria of mice. After 12 weeks of feeding the mice food with sucralose or food with water, the researchers found that the food with sucralose increased the amount of bacterium <em>Firmicutes</em> and decreased the amount of <em>Bacteroidetes</em>. There are thousands of bacteria in the intestines, but <em>Firmicutes</em> and <em>Bacteroidetes</em> are two of the most prevalent in humans. Scientists have noticed that in obese people, <em>Firmicutes</em> exist in high amounts while <em>Bacteroidetes</em> exist in lower amounts, which is the same trend the researchers found in the mouse experiment. Further research needs to be performed before a more justified link can be made between artificial sweeteners and obesity; however it’s clear that artificial sweeteners change the makeup of bacteria in our gut.</p><p>A lot still remains unknown about artificial sweeteners and their effects on the human body because it is difficult to test effectively with so many variables to control and ethics to consider. It is, however, definite that they affect the bacterial makeup in the human body. Sweet foods also generally increase appetite, so artificial sweeteners may increase one’s appetite like sugar does. There isn’t enough information yet to conclude whether artificial sweeteners are “healthier” than sugar, but like any food, moderation is key.</p><p><em>PLoS One</em> (2018). DOI: 10.1371/journal.pone.0199080</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6cd77ee1d6a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nusci/low-calorie-or-low-quality-6cd77ee1d6a">Low calorie or low quality?</a> was originally published in <a href="https://medium.com/nusci">NU Sci</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>